Pricing

Log inSign up

Yamo Pharmaceuticals

1 follower
‌

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Industries

Biotechnology, Pharmaceutical

Headquarters

New York, United States

Employees

1-10

Links

Org chart

CB
Chuck Bramlage
Chief Executive Officer
Collapse
Eugene Prahin
Chief Financial Officer
Tracy Fischer
Senior Vice President – Regulatory Affairs & Quality
BC
Brian Cahill
Chief Financial Officer

Teams

This company has no teams yet

Related companies

AbbVie

310 followers

Amgen

309 followers

Elanco

28 followers

Bristol-Myers Squibb

284 followers

Gilead Sciences

184 followers

Regeneron

151 followers

AtriCure

4 followers

Illumina

83 followers

Agilent Technologies

91 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

51 followers